Schizoaffective Disorders Completed Phase 3 Trials for Metformin (DB00331)

Also known as: Schizoaffective disorder / Schizophrenia schizoaffective / Schizoaffective psychosis / Schizo-affective type schizophrenia

IndicationStatusPhase
DBCOND0033299 (Schizoaffective Disorders)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00401973Assessment of Safety and Efficacy of Therapy for the Prevention of Weight Gain Associated With OlanzapinePrevention